Literature DB >> 15987300

Adamantiades-Behçet's disease, deep venous thrombosis and anticardiolipin antibodies: report of two cases.

L Kandolf-Sekulovic1, M D Pavlovic, B Glisic, M Petronijevic, G Ristic, Z Mijuskovic, R D Zecevic, D Stefanovic.   

Abstract

Vascular thrombosis was found in different proportions of patients with Adamantiades-Behçet's disease (ABD), depending on the ethnicity of the population under study. Various thrombophilic factors, including the levels of anticardiolipin antibodies (ACA), were investigated for their role in the thrombotic process with conflicting results. The prevalence of ACA varies considerably in different studies, but their presence has not been associated with increased risk for vascular thrombosis. We present two cases with ABD, deep venous thrombosis (DVT) and elevated levels of ACA that fulfil the criteria for both ABD and antiphospholipid syndrome (APS).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987300     DOI: 10.1111/j.1468-3083.2005.01193.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  3 in total

Review 1.  Etiopathogenesis of Behçet's disease with emphasis on the role of immunological aberrations.

Authors:  Violetta D Kapsimali; Meletios A Kanakis; George A Vaiopoulos; Phaedon G Kaklamanis
Journal:  Clin Rheumatol       Date:  2010-05-22       Impact factor: 2.980

2.  Auto-immunity profile evaluation during different clinical manifestations of Behçet disease in Algerian patients: effect of corticosteroid treatment.

Authors:  Fatmazohra Djaballah-Ider; Abdelhamid Djaballah; Zineb Djeraba; Samia Chaib; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2019-02-05       Impact factor: 4.473

3.  Adamantiades-Behcet disease (ABD) in northern Greece patients: experience from a single center.

Authors:  P Boura; K Tselios; P Skendros; S Kamali; A Sarantopoulos; M Raptopoulou-Gigi
Journal:  Hippokratia       Date:  2007-10       Impact factor: 0.471

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.